These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

559 related items for PubMed ID: 35911976

  • 1. Construction of a Necroptosis-Associated Long Non-Coding RNA Signature to Predict Prognosis and Immune Response in Hepatocellular Carcinoma.
    Wang W, Ye Y, Zhang X, Ye X, Liu C, Bao L.
    Front Mol Biosci; 2022; 9():937979. PubMed ID: 35911976
    [Abstract] [Full Text] [Related]

  • 2. Predicting Prognosis and Distinguishing Cold and Hot Tumors in Bladder Urothelial Carcinoma Based on Necroptosis-Associated lncRNAs.
    Liu D, Xu S, Chang T, Ma S, Wang K, Sun G, Chen S, Xu Y, Zhang H.
    Front Immunol; 2022; 13():916800. PubMed ID: 35860239
    [Abstract] [Full Text] [Related]

  • 3. Construction and validation of a necroptosis-related lncRNAs prognosis signature of hepatocellular carcinoma.
    Peng Y, Wu G, Qiu X, Luo Y, Zou Y, Wei X, Li A.
    Front Genet; 2022; 13():916024. PubMed ID: 36110223
    [Abstract] [Full Text] [Related]

  • 4. Construction of a cancer-associated fibroblasts-related long non-coding RNA signature to predict prognosis and immune landscape in pancreatic adenocarcinoma.
    Ye Y, Zhao Q, Wu Y, Wang G, Huang Y, Sun W, Zhang M.
    Front Genet; 2022; 13():989719. PubMed ID: 36212154
    [Abstract] [Full Text] [Related]

  • 5. A novel necroptosis-related lncRNA based signature predicts prognosis and response to treatment in cervical cancer.
    Du X, Pu X, Wang X, Zhang Y, Jiang T, Ge Y, Zhu H.
    Front Genet; 2022; 13():938250. PubMed ID: 36561319
    [Abstract] [Full Text] [Related]

  • 6. Identification and validation of a five-necroptosis-related lncRNAs signature for prognostic prediction in hepatocellular carcinoma.
    Chen H, Hou G, Lan T, Xue S, Xu L, Feng Q, Zeng Y, Wang H.
    Heliyon; 2024 Sep 30; 10(18):e37403. PubMed ID: 39309864
    [Abstract] [Full Text] [Related]

  • 7. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.
    Zhao QJ, Zhang J, Xu L, Liu FF.
    World J Gastroenterol; 2018 Aug 14; 24(30):3426-3439. PubMed ID: 30122881
    [Abstract] [Full Text] [Related]

  • 8. A Necroptosis-Related Gene Signature to Predict the Prognosis of Skin Cutaneous Melanoma.
    Xie Y, Xu Z, Mei X, Shi W.
    Dis Markers; 2022 Aug 14; 2022():8232024. PubMed ID: 36438905
    [Abstract] [Full Text] [Related]

  • 9. Analysis of m6A-related lncRNAs for prognostic and immunotherapeutic response in hepatocellular carcinoma.
    Wu X, Wang S, Wu X, Chen Q, Cheng J, Qi Z.
    J Cancer; 2024 Aug 14; 15(7):2045-2065. PubMed ID: 38434979
    [Abstract] [Full Text] [Related]

  • 10. A Novel Necroptosis-Related lncRNA Signature Predicts the Prognosis of Lung Adenocarcinoma.
    Lu Y, Luo X, Wang Q, Chen J, Zhang X, Li Y, Chen Y, Li X, Han S.
    Front Genet; 2022 Aug 14; 13():862741. PubMed ID: 35368663
    [Abstract] [Full Text] [Related]

  • 11. Construction of a novel necroptosis-related lncRNA signature for prognosis prediction in esophageal cancer.
    Liu Y, Hao H, Kang L, Zheng G, Guo X, Li B, Zhao H, Hao H.
    BMC Gastroenterol; 2022 Jul 15; 22(1):345. PubMed ID: 35840890
    [Abstract] [Full Text] [Related]

  • 12. Integrating bulk and single-cell RNA sequencing data to establish necroptosis-related lncRNA risk model and analyze the immune microenvironment in hepatocellular carcinoma.
    Zhang R, Li Q, Yu X, Hou Y, Yan L, Gao Y, Ji L, Zhang X, Fang M, Huang L, Yu Z, Gao Y, Li M.
    Heliyon; 2023 Nov 15; 9(11):e22083. PubMed ID: 38034714
    [Abstract] [Full Text] [Related]

  • 13. Identification of a novel defined inflammation-related long noncoding RNA signature contributes to predicting prognosis and distinction between the cold and hot tumors in bladder cancer.
    Xiong X, Chen C, Li X, Yang J, Zhang W, Wang X, Zhang H, Peng M, Li L, Luo P.
    Front Oncol; 2023 Nov 15; 13():972558. PubMed ID: 37064115
    [Abstract] [Full Text] [Related]

  • 14. Identification and Validation of Necroptosis-Related LncRNA Signature in Hepatocellular Carcinoma for Prognosis Estimation and Microenvironment Status.
    Chen C, Wu Y, Chen K, Xia Z, Liu X, Zhang C, Zhao H, Shen A.
    Front Genet; 2022 Nov 15; 13():898507. PubMed ID: 35754846
    [Abstract] [Full Text] [Related]

  • 15. Construction of a necroptosis-related lncRNA signature to predict the prognosis and immune microenvironment of head and neck squamous cell carcinoma.
    Huang J, Xu Z, Teh BM, Zhou C, Yuan Z, Shi Y, Shen Y.
    J Clin Lab Anal; 2022 Jun 15; 36(6):e24480. PubMed ID: 35522142
    [Abstract] [Full Text] [Related]

  • 16. Comprehensive analysis of immune-related gene signature based on ssGSEA algorithms in the prognosis and immune landscape of hepatocellular carcinoma.
    Wang L, Wang L, He P.
    Front Genet; 2022 Jun 15; 13():1064432. PubMed ID: 36568383
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Identification of metabolism-related long non-coding RNA (lncRNA) signature predicts prognosis and immune infiltrates in hepatocellular carcinoma.
    Wang X, Qian J, Yao N, Pocha C, Kang KJ, Angelico R, Zhu G.
    Ann Transl Med; 2022 May 15; 10(10):595. PubMed ID: 35722420
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.